Frontlight ResearchEarly access
HIV trials in Japan
4 of 4 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- Where
- Fukuoka, Kanagawa, Okinawa, Osaka, Tokyo
- Age
- 18 years and over
- People
- 186 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07202546 · EU 2025-521918-26-00 - Phase 3Taking peopleA Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- Where
- Aichi, Kanagawa, Osaka, Tokyo
- Age
- 12 years and over
- People
- 564 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00 - Phase 2Taking peopleA Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
- Where
- Bunkyo Ku, Osaka, Sapporo, Sendai
- Age
- 18 years to 79 years
- People
- 7
- Run by
- Kiminori Kimura, MD
See details and how to joinNCT07681089 - Phase 3Taking peopleStudy of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Where
- Osaka
- Age
- 18 years and over
- People
- 590 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT07682961